-
Testing COVID-19 Treatments for Patients With Cancer: An Ongoing Need
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
-
February 12: The Week in Cancer News
An FDA committee votes to recommend holding off on approval of an immunotherapy for early-stage triple-negative breast cancer, and physicians warn that enlarged lymph nodes after COVID-19 vaccination can be mistaken for signs of breast cancer.
by Kate Yandell
-
February 5: The Week in Cancer News
Fecal transplants may improve immunotherapy responses, and more than half of cancer survivors have at least one additional condition that increases their risk of severe COVID-19.
by Kevin McLaughlin
-
January 29: The Week in Cancer News
Advocates are asking that cancer patients be prioritized for COVID-19 vaccination, and a KRAS inhibitor shows promising phase II trial results.
by Kate Yandell
-
January 15: The Week in Cancer News
People are using crowdsourced fundraising to cover cancer care costs, and missed cancer screenings due to COVID-19 may have led to fewer missed diagnoses than feared.
by Kevin McLaughlin
-
2020: This Year in Cancer News
The Cancer Today editorial staff selects some of the most impactful reporting and essays of 2020.
by Cancer Today Staff
-
December 18: The Week in Cancer News
Researchers estimate that breast cancer surpassed lung cancer as the most commonly diagnosed cancer globally in 2020, and a study provides insight into financial toxicity's impact on quality of life.
by Bradley Jones
-
December 11: The Week in Cancer News
The San Antonio Breast Cancer Symposium and American Society of Hematology meeting go virtual, and COVID-19 brings silver linings to cancer clinical trials.
by Marci A. Landsmann
-
December 4: The Week in Cancer News
Many people who pursue low-dose CT lung cancer screening do not follow the recommended screening schedule, and U.K. scientists say the COVID-19 pandemic has set back progress in cancer research.
by Kevin McLaughlin
-
November 20: The Week in Cancer News
Researchers investigate why some patients respond exceptionally well to cancer treatment, and the Food and Drug Administration approves a second immunotherapy drug for some breast cancer patients.
by Kate Yandell
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore